Educational content on VJRegenMed is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2020 | Cellular therapies: from academia to industry

Jürgen Kuball • 1 Sep 2020
EBMT 2020
CAR-T

Jürgen Kuball, MD, PhD, Utrecht University, Utrecht University, Netherlands, discusses how cellular therapies are translated from academia to industrial partners and any challenges associated with this. This interview was recorded via an online conference call with The Video Journal of Regenerative Medicine (VJRegenMed).

More from Jürgen Kuball

0:55
Multivalent gamma-delta T-cells: promising agents for the treatment of cancers
Jürgen Kuball • 10 Feb 2023
2:28
The regulatory process for CAR-T in Europe: EBMT registry & GoCART
Jürgen Kuball • 27 Jan 2021
0:49
CAR-T regulatory issues and reimbursements
Jürgen Kuball • 27 Jan 2021
1:26
Sharing CAR T-cell data: an EBMT perspective
Jürgen Kuball • 1 Sep 2020
The content of VJRegenMed is intended for healthcare professionals